Literature DB >> 30496838

European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest.

Jasmeet Soar1, Gavin D Perkins2, Ian Maconochie2, Bernd W Böttiger2, Charles D Deakin2, Claudio Sandroni2, Theresa M Olasveengen2, Jonathan Wyllie2, Robert Greif2, Andrew Lockey2, Federico Semeraro2, Patrick Van de Voorde2, Carsten Lott2, Leo Bossaert2, Koenraad G Monsieurs2, Jerry P Nolan2.   

Abstract

This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Advanced life support; Amiodarone; Antiarrhythmic drugs; Cardiopulmonary resuscitation; Guidelines; Heart arrest; Lidocaine; Neonatal life support; Paediatric life support; Pulseless ventricular tachycardia; Ventricular fibrillation

Mesh：

Substances：

Year:  2018        PMID： 30496838     DOI： 10.1016/j.resuscitation.2018.11.018

Source DB:  PubMed          Journal:  Resuscitation        ISSN： 0300-9572            Impact factor:   5.262


  8 in total

Review 1.  Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.

Authors:  Goran Koracevic; Milovan Stojanovic; Dragan Lovic; Marija Zdravkovic; Dejan Sakac
Journal:  J Hum Hypertens       Date:  2021-03-02       Impact factor: 3.012

2.  Cardiopulmonary resuscitation retention training for hospital nurses by a self-learner skill station or the traditional instructor led course: A randomised controlled trial.

Authors:  Kristoffer Sand; Anna Ulstein Guldal; Tor Åge Myklebust; Dag Arne Lihaug Hoff; Per Christian Juvkam; Torstein Hole
Journal:  Resusc Plus       Date:  2021-08-19

3.  [Recommendations on cardiopulmonary resuscitation in patients with suspected or confirmed SARS-CoV-2 infection (COVID-19). Executive summary].

Authors:  M A Rodríguez Yago; I Alcalde Mayayo; R Gómez López; M N Parias Ángel; A Pérez Miranda; M Canals Aracil; E Civantos Fuentes; A Rodríguez Núñez; I Manrique Martínez; J López-Herce Cid; G Zeballos Sarrato; C Calvo Macías; A Hernández-Tejedor
Journal:  Med Intensiva (Engl Ed)       Date:  2020-05-16

Review 4.  Drug use during adult advanced cardiac life support: An overview of reviews.

Authors:  Hans Vandersmissen; Hanne Gworek; Philippe Dewolf; Marc Sabbe
Journal:  Resusc Plus       Date:  2021-08-13

5.  Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity.

Authors:  Alina M Bețiu; Imen Chamkha; Ellen Gustafsson; Elna Meijer; Vlad F Avram; Eleonor Åsander Frostner; Johannes K Ehinger; Lucian Petrescu; Danina M Muntean; Eskil Elmér
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

6.  CLInical Profile and Side Effects of chronic use of oral Amiodarone in cardiology outpatients department (CLIPSE-A Study)- A prospective observational study.

Authors:  Nabeela Fatima; Kiranmai Mandava; Fatima Khatoon; Juveria Badar; Syeda Fatima Begum; C Narasimhan; K Daljeet; Walli Mohammed
Journal:  Ann Med Surg (Lond)       Date:  2022-07-16

Review 7.  [Adult advanced life support].

Authors:  Jasmeet Soar; Bernd W Böttiger; Pierre Carli; Keith Couper; Charles D Deakin; Therese Djärv; Carsten Lott; Theresa Olasveengen; Peter Paal; Tommaso Pellis; Gavin D Perkins; Claudio Sandroni; Jerry P Nolan
Journal:  Notf Rett Med       Date:  2021-06-08       Impact factor: 0.826

Review 8.  [Executive summary].

Authors:  Gavin D Perkins; Jan-Thorsten Gräsner; Federico Semeraro; Theresa Olasveengen; Jasmeet Soar; Carsten Lott; Patrick Van de Voorde; John Madar; David Zideman; Spyridon Mentzelopoulos; Leo Bossaert; Robert Greif; Koen Monsieurs; Hildigunnur Svavarsdóttir; Jerry P Nolan
Journal:  Notf Rett Med       Date:  2021-06-02       Impact factor: 0.892
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.